396 related articles for article (PubMed ID: 30826501)
21. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
22. Midlife Modifiable Risk Factors for Dementia: A Systematic Review and Meta-analysis of 34 Prospective Cohort Studies.
Li XY; Zhang M; Xu W; Li JQ; Cao XP; Yu JT; Tan L
Curr Alzheimer Res; 2019; 16(14):1254-1268. PubMed ID: 31902364
[TBL] [Abstract][Full Text] [Related]
23. Causes of hyperhomocysteinemia and its pathological significance.
Kim J; Kim H; Roh H; Kwon Y
Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
[TBL] [Abstract][Full Text] [Related]
24. [Homocysteine and dementia].
Kessler H; Bleich S; Falkai P; Supprian T
Fortschr Neurol Psychiatr; 2003 Mar; 71(3):150-6. PubMed ID: 12624852
[TBL] [Abstract][Full Text] [Related]
25. Effect of antioxidant intake patterns on risks of dementia and cognitive decline.
Zhou F; Xie X; Zhang H; Liu T
Eur Geriatr Med; 2023 Feb; 14(1):9-17. PubMed ID: 36445640
[TBL] [Abstract][Full Text] [Related]
26. Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies.
Atti AR; Valente S; Iodice A; Caramella I; Ferrari B; Albert U; Mandelli L; De Ronchi D
Am J Geriatr Psychiatry; 2019 Jun; 27(6):625-637. PubMed ID: 30917904
[TBL] [Abstract][Full Text] [Related]
27. Association between Homocysteine Levels and All-cause Mortality: A Dose-Response Meta-Analysis of Prospective Studies.
Fan R; Zhang A; Zhong F
Sci Rep; 2017 Jul; 7(1):4769. PubMed ID: 28684797
[TBL] [Abstract][Full Text] [Related]
28. Association between Antihypertensive Drug Use and the Incidence of Cognitive Decline and Dementia: A Meta-Analysis of Prospective Cohort Studies.
Xu G; Bai F; Lin X; Wang Q; Wu Q; Sun S; Jiang C; Liang Q; Gao B
Biomed Res Int; 2017; 2017():4368474. PubMed ID: 29094046
[TBL] [Abstract][Full Text] [Related]
29. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
30. Coffee intake and the incident risk of cognitive disorders: A dose-response meta-analysis of nine prospective cohort studies.
Wu L; Sun D; He Y
Clin Nutr; 2017 Jun; 36(3):730-736. PubMed ID: 27288328
[TBL] [Abstract][Full Text] [Related]
31. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
Kwok T; Lee J; Law CB; Pan PC; Yung CY; Choi KC; Lam LC
Clin Nutr; 2011 Jun; 30(3):297-302. PubMed ID: 21216507
[TBL] [Abstract][Full Text] [Related]
32. Homocysteine and cognitive performance in healthy elderly subjects.
Ravaglia G; Forti P; Maioli F; Scali RC; Saccheitti L; Talerico T; Mantovani V; Bianchin M
Arch Gerontol Geriatr Suppl; 2004; (9):349-57. PubMed ID: 15207433
[TBL] [Abstract][Full Text] [Related]
33. Dietary Fat Intake and Cognitive Function among Older Populations: A Systematic Review and Meta-Analysis.
Cao GY; Li M; Han L; Tayie F; Yao SS; Huang Z; Ai P; Liu YZ; Hu YH; Xu B
J Prev Alzheimers Dis; 2019; 6(3):204-211. PubMed ID: 31062836
[TBL] [Abstract][Full Text] [Related]
34. From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.
Siuda J; Gorzkowska A; Patalong-Ogiewa M; Krzystanek E; Czech E; Wiechuła B; Garczorz W; Danch A; Jasińska-Myga B; Opala G
Neurol Neurochir Pol; 2009; 43(4):321-9. PubMed ID: 19742390
[TBL] [Abstract][Full Text] [Related]
35. Handgrip strength and risk of cognitive outcomes: new prospective study and meta-analysis of 16 observational cohort studies.
Kunutsor SK; Isiozor NM; Voutilainen A; Laukkanen JA
Geroscience; 2022 Aug; 44(4):2007-2024. PubMed ID: 35013908
[TBL] [Abstract][Full Text] [Related]
36. Tea intake or consumption and the risk of dementia: a meta-analysis of prospective cohort studies.
Jiang N; Ma J; Wang Q; Xu Y; Wei B
PeerJ; 2023; 11():e15688. PubMed ID: 37483967
[TBL] [Abstract][Full Text] [Related]
37. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
38. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Passaro A; Bergamini CM; Pilotto A; Zuliani G
J Neurol Sci; 2014 Feb; 337(1-2):156-61. PubMed ID: 24321755
[TBL] [Abstract][Full Text] [Related]
39. The risk of dementia or cognitive impairment in patients with cataracts: a systematic review and meta-analysis.
Wang L; Sang B; Zheng Z
Aging Ment Health; 2024; 28(1):11-22. PubMed ID: 37416949
[TBL] [Abstract][Full Text] [Related]
40. The association between orthostatic hypotension and dementia: A meta-analysis of prospective cohort studies.
Min M; Shi T; Sun C; Liang M; Zhang Y; Wu Y; Sun Y
Int J Geriatr Psychiatry; 2018 Dec; 33(12):1541-1547. PubMed ID: 30247788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
